Pfizer Inc
(MIL:1PFE)
€
24.625
-0.16 (-0.65%)
Market Cap: 138.78 Bil
Enterprise Value: 192.52 Bil
PE Ratio: 34.89
PB Ratio: 1.59
GF Score: 64/100 Pfizer Inc at Truist BioPharma Symposium Transcript
Nov 09, 2023 / 05:35PM GMT
Robyn Kay Shelton Karnauskas
Truist Securities, Inc., Research Division - Research Analyst
All right. Good afternoon. Thanks so much for joining us. I'm Robyn Karnauskas, one of the biotech analysts at Truist. I'm so excited to have for a keynote this afternoon from Pfizer, Aamir Malik, the Chief Business Innovation Officer and Executive Vice President. So thank you very much for taking the time and doing this talk instead of doing more important things. I really appreciate it.
Aamir Malik
Pfizer Inc. - Executive VP & Chief Business Innovation Officer
It's nice to be with you. Thanks for having me.
Questions & Answers
Robyn Kay Shelton Karnauskas;Aamir Malik
Truist Securities, Inc., Research Division - Research Analyst;Pfizer Inc. - Executive VP
So I guess the first question is, given your role as the Chief Business Innovation Officer, how do you see Pfizer's approach to innovation compared to other pharma companies? And how does Pfizer think about this differently?
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot